Statistics for Development and characterization of a novel model of ibrutinib resistance in Chronic Lymphocytic Leukemia (CLL) that displays sensitivity to PI3K inhibition

Total visits

views
Development and characterization of a novel model of ibrutinib resistance in Chronic Lymphocytic Leukemia (CLL) that displays sensitivity to PI3K inhibition 192

Total visits per month

views
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 1
April 2025 0
May 2025 0

File Visits

views
Ehiremen_Godsent.pdf 176
GEhiremen_masters_thesis_practicum_final_report.pdf 1

Top country views

views
United States 47
Canada 34
China 26
Ireland 17
Hong Kong SAR China 13
Germany 12
India 9
Italy 6
United Kingdom 3
Finland 2
South Korea 2
Saudi Arabia 2
Sweden 2
Singapore 2
Taiwan 2
Vietnam 2
Cyprus 1
Spain 1
Iran 1
Nigeria 1
Netherlands 1
Poland 1

Top city views

views
Winnipeg 31
Beijing 18
Ashburn 17
Dublin 10
Babail 3
Miami 3
Padova 3
Tokyo 3
Zhengzhou 3
Bengaluru 2
Clifton 2
Hanoi 2
Helsinki 2
Hyderabad 2
Inglewood 2
Barcelona 1
Brooklyn 1
Busanjin-gu 1
Calgary 1
Central 1
Chieti 1
City of Saint Peters 1
Des Moines 1
El Cajon 1
Fairless Hills 1
Gulou 1
Karlstad 1
Katowice 1
Kernersville 1
Lagos 1
Las Vegas 1
Leicester 1
Lincoln 1
Los Angeles 1
Lund 1
Mogliano Veneto 1
Mumbai 1
Nagold 1
New York 1
Nijmegen 1
Oklahoma City 1
Pescara 1
Richmond 1
Seattle 1
Shanghai 1
Shenzhen 1
Silver Spring 1
Singapore 1
Stanford 1
Surat 1
Yongsan-gu 1
Zhangzhou 1